HOME >> MEDICINE >> NEWS
Bias in statin trials, failure to control malaria, and more

In this weeks press release:

  • Findings depend on who has funded the research

  • Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR 1/FLT1

  • Donors and international health agencies are failing Africa on malaria control

  • Teaching global health at the frontlines


Findings depend on who has funded the research

Research on the effectiveness of a major class of drug statins, used to reduce cholesterol has come under the spotlight in a new article published in PLoS Medicine. There are several statins now on the market and many research trials have compared different brands of statin head-to-head. The authors of the article looked at nearly 200 such trials, some were funded by governments, some by pharmaceutical companies, and in some cases the source of the funding had not been made clear. The authors found that trials of head-to-head comparisons were more likely to report results and conclusions favouring the sponsors own product than the drug with which it was compared

Lisa Bero and colleagues at the University of California, San Francisco argue that their findings show that the type of sponsorship available for randomized controlled trials of statins was strongly linked to the results and conclusions of those studies, even when other factors were taken into account. However, it is not clear from this study why sponsorship has such a strong link to the overall findings. There are many possible reasons why this might be. It has been suggested that drug companies may deliberately choose lower dosages for the comparison drug when they carry out head-to-head trials. Others have suggested that trials which produce unfavourable results are not published, or that unfavourable outcomes are suppressed. Whatever the reasons, the conclusions of this article are im
'"/>

Contact: Andrew Hyde
44-122-346-3330
Public Library of Science
4-Jun-2007


Page: 1 2 3 4 5 6

Related medicine news :

1. Could statins be a new option for hepatitis C patients?
2. Early statin therapy for patients with acute coronary syndromes reduces death, cardiovascular events
3. Patients can report statins adverse effects on new web site
4. UC Davis researchers find added benefit of statins in those at high risk for heart disease, diabetes
5. Popular statin reduces recurrent stroke risk
6. Cancer drug is first to alleviate devastating scleroderma symptoms
7. Early use of statins after coronary syndromes does not reduce risk of heart attack, stroke or death
8. Weekly religious attendance nearly as effective as statins and exercise in extending life
9. Very high-intensity statin therapy shows promise for inducing regression of coronary atherosclerosis
10. Intensive statin therapy may partially reverse plaque build-up in arteries
11. A protein fragment called 12.5 kda cystatin may generate first simple test for multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
Breaking Medicine Technology:
Cached News: